Tumor stromal disrupting agent enhances the anticancer efficacy of docetaxel loaded PEGylated liposomes in lung cancer
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Tumor stromal disrupting agent enhances the anticancer efficacy of docetaxel loaded PEGylated liposomes in lung cancer
Authors
Keywords
-
Journal
Nanomedicine
Volume 11, Issue 11, Pages 1377-1392
Publisher
Future Medicine Ltd
Online
2016-05-12
DOI
10.2217/nnm.16.37
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Tumor neovasculature-targeted cationic PEGylated liposomes of gambogic acid for the treatment of triple-negative breast cancer
- (2015) Ravi Doddapaneni et al. DRUG DELIVERY
- Piperlongumine for Enhancing Oral Bioavailability and Cytotoxicity of Docetaxel in Triple-Negative Breast Cancer
- (2015) Ketan Patel et al. JOURNAL OF PHARMACEUTICAL SCIENCES
- Taxanes, past, present, and future impact on non-small cell lung cancer
- (2014) Monika Joshi et al. ANTI-CANCER DRUGS
- Cancer treatment and survivorship statistics, 2014
- (2014) Carol E. DeSantis et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Oral delivery of paclitaxel nanocrystal (PNC) with a dual Pgp-CYP3A4 inhibitor: Preparation, characterization and antitumor activity
- (2014) Ketan Patel et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- Antitumor activity of PEGylated biodegradable nanoparticles for sustained release of docetaxel in triple-negative breast cancer
- (2014) Giuseppe Palma et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- Nanoparticles Functionalized with Collagenase Exhibit Improved Tumor Accumulation in a Murine Xenograft Model
- (2014) Surya Murty et al. PARTICLE & PARTICLE SYSTEMS CHARACTERIZATION
- EphA2 Targeting Pegylated Nanocarrier Drug Delivery System for Treatment of Lung Cancer
- (2014) Apurva R. Patel et al. PHARMACEUTICAL RESEARCH
- Improving Conventional Enhanced Permeability and Retention (EPR) Effects; What Is the Appropriate Target?
- (2014) Hisataka Kobayashi et al. Theranostics
- Two-Wave Nanotherapy To Target the Stroma and Optimize Gemcitabine Delivery To a Human Pancreatic Cancer Model in Mice
- (2013) Huan Meng et al. ACS Nano
- Synthesis and in vitro studies of gold nanoparticles loaded with docetaxel
- (2013) Rachel de Oliveira et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- Medium Chain Triglyceride (MCT) Rich, Paclitaxel Loaded Self Nanoemulsifying Preconcentrate (PSNP): A Safe and Efficacious Alternative to Taxol®
- (2013) Ketan Patel et al. Journal of Biomedical Nanotechnology
- Inhalation delivery of Telmisartan enhances intratumoral distribution of nanoparticles in lung cancer models
- (2013) Chandraiah Godugu et al. JOURNAL OF CONTROLLED RELEASE
- Angiotensin inhibition enhances drug delivery and potentiates chemotherapy by decompressing tumour blood vessels
- (2013) Vikash P. Chauhan et al. Nature Communications
- Surface Engineering of Liposomes for Stealth Behavior
- (2013) Okhil Nag et al. Pharmaceutics
- A novel leaflet-selective fluorescence labeling technique reveals differences between inner and outer leaflets at high bilayer curvature
- (2012) Salvatore Chiantia et al. BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES
- Hepatocellular carcinoma targeting effect of PEGylated liposomes modified with lactoferrin
- (2012) Minyan Wei et al. EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES
- n-Butanol Partitioning and Phase Behavior in DPPC/DOPC Membranes
- (2012) Yogi Kurniawan et al. JOURNAL OF PHYSICAL CHEMISTRY B
- Inhibition of Mammary Tumor Growth Using Lysyl Oxidase-Targeting Nanoparticles to Modify Extracellular Matrix
- (2012) Mathumai Kanapathipillai et al. NANO LETTERS
- Targeting the TGFβ signalling pathway in disease
- (2012) Rosemary J. Akhurst et al. NATURE REVIEWS DRUG DISCOVERY
- TGF- blockade improves the distribution and efficacy of therapeutics in breast carcinoma by normalizing the tumor stroma
- (2012) J. Liu et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Hyaluronidase and Collagenase Increase the Transfection Efficiency of Gene Electrotransfer in Various Murine Tumors
- (2011) Maja Cemazar et al. HUMAN GENE THERAPY
- AFM, ESEM, TEM, and CLSM in liposomal characterization: a comparative study
- (2011) Barbara Ruozi et al. International Journal of Nanomedicine
- Vitamin E TPGS coated liposomes enhanced cellular uptake and cytotoxicity of docetaxel in brain cancer cells
- (2011) Madaswamy S. Muthu et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- Targeted drug delivery to tumors: Myths, reality and possibility
- (2011) You Han Bae et al. JOURNAL OF CONTROLLED RELEASE
- Drug targeting to tumors: Principles, pitfalls and (pre-) clinical progress
- (2011) Twan Lammers et al. JOURNAL OF CONTROLLED RELEASE
- Intracellular targeting delivery of liposomal drugs to solid tumors based on EPR effects
- (2010) Kazuo Maruyama ADVANCED DRUG DELIVERY REVIEWS
- Gemcitabine-loaded PEGylated unilamellar liposomes vs GEMZAR®: Biodistribution, pharmacokinetic features and in vivo antitumor activity
- (2010) Donatella Paolino et al. JOURNAL OF CONTROLLED RELEASE
- Transfer mechanism of temoporfin between liposomal membranes
- (2010) Hossam Hefesha et al. JOURNAL OF CONTROLLED RELEASE
- All-trans retinoic acid stealth liposomes prevent the relapse of breast cancer arising from the cancer stem cells
- (2010) Ruo-Jing Li et al. JOURNAL OF CONTROLLED RELEASE
- Delivering nanomedicine to solid tumors
- (2010) Rakesh K. Jain et al. Nature Reviews Clinical Oncology
- Enhancement of Docetaxel Anticancer Activity by a Novel Diindolylmethane Compound in Human Non-Small Cell Lung Cancer
- (2009) N. Ichite et al. CLINICAL CANCER RESEARCH
- Antitumor activity of noscapine in human non-small cell lung cancer xenograft model
- (2008) Tanise Jackson et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started